0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cisplatin: from DNA damage to cancer chemotherapy.

      Progress in nucleic acid research and molecular biology
      Amino Acid Sequence, Antineoplastic Agents, pharmacology, therapeutic use, Cisplatin, chemistry, metabolism, DNA Adducts, DNA Damage, High Mobility Group Proteins, Kinetics, Molecular Sequence Data, Molecular Structure, Protein Binding, Sequence Homology, Amino Acid, Thermodynamics

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cisplatin [cis-DDP, cis-diamminedichloroplatinum(II)] is a potent anticancer drug that has been used successfully to treat tumors of the head, neck, lungs, and genitourinary tract. The biological activity of cisplatin was discovered serendipitously more than 30 years ago, and since that time research efforts have focused on elucidating its mechanism of action. The present review provides a historical perspective of our attempts to understand this complex phenomenon and the results of recent work that guides our current activities in this field. Continued efforts to understand the mechanism of genotoxicity of cisplatin are expected to lead to the discovery of new drugs and combinations for the improvement of cancer chemotherapy.

          Related collections

          Author and article information

          Comments

          Comment on this article